Skip to main content

Table 3 Plaque progression in different tertiles of MPO activity in patients with type 2 diabetes

From: Serum MPO levels and activities are associated with angiographic coronary atherosclerotic plaque progression in type 2 diabetic patients

Tertiles of MPO activity

n

Follow-up duration, (months)

Plaque progression, n (%)

Changes in MLD, (mm)

Changes in stenosis diameter, (%)

Changes in CCSS

T1

83

12.22 ± 1.08

43 (51.8)

0.28 ± 0.40

 − 9.08 ± 13.23

 − 0.14 ± 0.19

T2

82

12.16 ± 0.84

52 (63.4)

0.40 ± 0.39

 − 13.69 ± 13.57

 − 0.21 ± 0.19

T3

83

12.43 ± 1.69

66 (79.5)

0.58 ± 0.37

 − 20.51 ± 12.65

 − 0.31 ± 0.20

P value

 

0.335

0.001

 < 0.001

 < 0.001

 < 0.001

  1. Values are given as mean ± standard deviation (SD) or number (percentage)
  2. Change of QCA measurement is defined as baseline QCA measurement minus follow-up measurement
  3. Tertiles of MPO activity: T1 ≤ 6.0307 mU/mL; 6.0307 < T2 ≤ 9.8684 mU/mL; T3 > 9.8684 mU/mL
  4. MLD Minimal lumen diameter, CCSS Cumulative coronary stenosis score, QCA Quantitative coronary analyses
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us